Pharmaceutical company
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | AMNEAL PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$190,000 | |
| 2026 | AMNEAL PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$190,000 | |
| 2025 | AMNEAL PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$340,000 | |
| 2025 | AMNEAL PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$310,000 | |
| 2025 | AMNEAL PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$210,000 | |
| 2025 | AMNEAL PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$910,000 | |
| 2024 | AMNEAL PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$210,000 | |
| 2024 | AMNEAL PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) AMENDED |
$230,000 | |
| 2024 | AMNEAL PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) AMENDED |
$240,000 | |
| 2024 | AMNEAL PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) AMENDED |
$850,000 |
| Firm | Filings | Expenses |
|---|---|---|
| AMNEAL PHARMACEUTICALS | 16 | $3,680,000 |
| Issue | Activities |
|---|---|
| Health Issues | 16 |